Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2022-11-22 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Disclosure pursuant to Grant of 177781 stock options under Employees Stock Option Plans.
Regulatory Filings Classification · 95% confidence The document text is extremely short (514 characters) and contains only a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no mention of any report type, regulatory body, fiscal period, or corporate event. Given the lack of content and the nature of the text, it does not fit into any specific filing category. According to the rules, such documents that do not neatly fit anywhere else should be classified as Regulatory Filings (RNS).
2022-11-22 English
ESOP/ESPS/SBEB Scheme
Regulatory Filings Classification · 100% confidence The document text is extremely short (516 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no mention of any report type, regulatory body, fiscal period, or corporate event. Given the lack of any report or announcement content, and the presence of only a signature, this document does not fit into any specific filing category. According to the rules, such documents fall under the fallback category of Regulatory Filings (RNS).
2022-11-21 English
Disclosure pursuant to allotment of 42114 shares under ESOP.
Regulatory Filings Classification · 95% confidence The document text is extremely short (569 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no indication of any report, announcement, or financial data. Given the lack of content and the nature of the text, this is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2022-11-21 English
Lupin Signs MoU with the Government of Rajasthan to strengthen Healthcare system.
Regulatory Filings Classification · 95% confidence The document is a press note announcing that Lupin Limited has signed a Memorandum of Understanding (MoU) with the Government of Rajasthan to strengthen healthcare systems and address diseases in a specific region. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015. The content focuses on a corporate social responsibility initiative and partnership, not on financial results, management changes, or regulatory filings. The document is about a corporate announcement related to social responsibility and partnership, not a financial report or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-11-21 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press note announcing that Lupin Limited has signed a Memorandum of Understanding (MoU) with the Government of Rajasthan to strengthen healthcare systems. It is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content focuses on a corporate social responsibility initiative and collaboration details, not on financial results, management changes, or regulatory filings. It is not a report, transcript, or financial statement but an announcement of a corporate event. The document length is 8138 characters, which is substantial but the content is clearly a press release-type disclosure. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2022-11-21 English
Transcript of Q2 FY2023 Earnings Conference Call.
Call Transcript Classification · 100% confidence The document is a transcript of the Q2 FY2023 earnings conference call for Lupin Limited, dated November 10, 2022. It includes detailed management commentary on financial performance, business highlights, product launches, acquisitions, and a Q&A session with analysts. The presence of a full transcript of the earnings call, including management discussion and Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2022-11-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.